PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.22%
Negative revenue growth while UPM.HE stands at 1.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.30%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
4125.00%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
4125.00%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
1033.33%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
972.21%
EPS growth above 1.5x UPM.HE's 69.57%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
972.21%
Diluted EPS growth above 1.5x UPM.HE's 69.57%. David Dodd would see if there's a robust moat protecting these shareholder gains.
7.56%
Share change of 7.56% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
7.56%
Slight or no buyback while UPM.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-214.29%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-372.22%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-9.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-9.55%
Negative 5Y CAGR while UPM.HE stands at 3.53%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-9.55%
Negative 3Y CAGR while UPM.HE stands at 40.20%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-62.18%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-62.18%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-62.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
249.37%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
249.37%
5Y net income/share CAGR above 1.5x UPM.HE's 144.07%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
249.37%
Below 50% of UPM.HE's 1175.87%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.33%
Inventory is declining while UPM.HE stands at 4.08%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.65%
Negative asset growth while UPM.HE invests at 0.48%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.01%
1.25-1.5x UPM.HE's 2.51%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-0.53%
We’re deleveraging while UPM.HE stands at 1.39%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.